Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion

NCT02338466 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Departure of the principal investigator and lack of succession

Conditions

Nervous System Disorders
Cerebral Artery

Interventions

DRUG: rt-PA
DRUG: tenecteplase

Sponsor

University Hospital Center of Martinique